Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB12120InvestigationalSmall molecule
Avoralstat has been used in trials studying the prevention of HAE and Hereditary Angioedema.
- Mechanism
- Curator reviewed
Pharmacologically active on Plasma kallikrein
- Formula / weight
- C28H27N5O5 · 513.554 g/mol (avg)
- Also known as
- 3-(2-((4-Carbamimidoylphenyl)carbamoyl)-4-ethenyl-5-methoxyphenyl)-6-((cyclopropylmethyl)carbamoyl)pyridine-2-carboxylic acid · 3-[2-(4-carbamimidoyl-phenylcarbamoyl)-5-methoxy-4-vinyl-phenyl]-6-(cyclopropylmethyl-carbamoyl)-pyridine-2-carboxylic acid · 3-[2-[(4-carbamimidoylphenyl)carbamoyl]-4-ethenyl-5-methoxyphenyl]-6-(cyclopropylmethylcarbamoyl)pyridine-2-carboxylic acid
- Code names
- BCX-4161
Resolves to
Structure
InChIKey
TUWMKPVJGGWGNL-UHFFFAOYSA-NSMILESCOC1=CC(=C(C=C1C=C)C(=O)NC1=CC=C(C=C1)C(N)=N)C1=CC=C(N=C1C(O)=O)C(=O)NCC1CC1What you can answer from here — as of June 15, 2026
Which drugs share a target with Avoralstat, and which of those have an active Phase 3 trial?